ANAPTYSBIO, INC
SEC insider (Form 3/4/5 filer). CIK 0001370053. 10% Owner at First Tracks Biotherapeutics, Inc. (TRAX). 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 20, 2026. Located in SAN DIEGO, CA.
Companies ANAPTYSBIO, INC has filed insider reports for
- First Tracks Biotherapeutics, Inc. (TRAX): 10% Owner
ANAPTYSBIO, INC
CIK: 0001370053
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TRAX
First Tracks Biotherapeutics, Inc.
10% Owner